News yesterday that a scientific study found Vioxx raised risk of heart attacks after as little as four months of use could hurt Merck's legal strategy against many Vioxx lawsuits. Stacey Vanek-Smith explains.
No surprise that the cost of brand-name prescription drugs is on the rise, but a new study reveals the cost has skyrocketed this year — three times faster than the rate of inflation. Stacey Vanek-Smith reports.
With yesterday's favorable IPO by ethanol producer VeraSun, Stacey Vanek-Smith looks at investor enthusiasm for public offerings from other biofuel companies.
A bankruptcy court has given the thumbs-up to deals Northwest Airlines struck with pilots, baggage handlers and ground workers. But there's still no agreement with one important group of workers. Stacey Vanek-Smith reports.
The White House yesterday released a rosier forecast for economic growth than originally estimated, but some economists see the glass a little differently. Stacey Vanek-Smith reports.
A college student pleaded guilty yesterday to charges he conned investors into pouring millions into a bogus hedge fund named for the mythical architect who confounded many a Greek with his complex labyrinth. Stacey Vanek-Smith reports.
They're supposed to promote home ownership through more affordable mortgages, but a Fed economist says government-sponsored lenders Fannie Mae and Freddie Mac are lining shareholder pockets instead. Stacey Vanek-Smith reports.
The SEC announced yesterday it will not exempt small businesses from strict Sarbanes-Oxley accounting standards meant to prevent Enron-style fraud. Stacey Vanek-Smith reports.
